Capstone Development Services is an innovative shared services development company focused exclusively on complex generic pharmaceuticals and medical devices. Founded by strategic healthcare investor Water Street Healthcare Partners, Capstone leads development, manages regulatory services, and achieves timely approval of healthcare products through partnerships with global pharmaceutical and medical companies. To date, Capstone has developed and gained regulatory approvals on more than 20 products in the United States, European Union, and Canada – and continues to bring additional new and affordable healthcare products to market. Capstone serves as a holding company that houses multiple development partnerships, including; Celerity Pharmaceuticals, Gage Development Company, Balmoral Medical, Orchard Medical Development and Loop Therapeutics, and one commercial pharmaceutical company, Long Grove Pharmaceuticals.